<DOC>
	<DOCNO>NCT02776046</DOCNO>
	<brief_summary>The iPROVE-O2 trial aim compare efficacy high conventional FiO2 within perioperative individualized ventilatory strategy reduce overall incidence SSI .</brief_summary>
	<brief_title>Individualized Perioperative Open-lung Ventilatory Strategy With High Versus Conventional Inspiratory Oxygen Fraction ( iPROVE-O2 ) .</brief_title>
	<detailed_description />
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Hyperoxia</mesh_term>
	<criteria>Age le 18 Planned abdominal surgery &gt; 2 hour . Signed informed consent participation study . Age le 18 year . Pregnant breastfeeding . Patients BMI &gt; 35 . Syndrome moderate severe respiratory distress : PaO2/FiO2 &lt; 200 mmHg . Heart failure : NYHA IV . Hemodynamic failure : CI &lt; 2.5 L/min/m2 / requirement surgery ionotropic support . Diagnosis suspicion intracranial hypertension ( intracranial pressure &gt; 15 mmHg ) . Mechanical ventilation last 15 day . Presence pneumothorax . Presence giant bulla chest radiography compute tomography ( CT ) . Patient preoperatively CPAP . Participation another experimental protocol time intervention selection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Oxygen , surgical site infection , postoperative complication , recruitment maneuver , open lung strategy</keyword>
</DOC>